Literature DB >> 26332048

TLR-7 and -9 Stimulation of Peripheral Blood B Cells Indicate Altered TLR Signalling in Primary Sjögren's Syndrome Patients by Increased Secretion of Cytokines.

M Karlsen1, R Jonsson1,2, J G Brun2,3, S Appel1, T Hansen3,4.   

Abstract

Primary Sjögren's syndrome (pSS) is a chronic, inflammatory autoimmune disease characterised by lymphocytic infiltrations in the exocrine glands, resulting in destruction of salivary and lacrimal glands. B cells have an important role in the disease, as detection of autoantibodies against SSA/Ro or SSB/La is one of the diagnostic criteria, being found in a majority of the patients. Toll-like receptors (TLR) are pattern recognition receptors. TLR-7 and -9 are found in endosomes and bind microbial nucleic acids. We have previously shown that pSS patients and healthy controls have similar expression pattern of TLR-7 and -9 in various B-cell populations. In this study we further analysed the responsiveness of B cells upon TLR stimulation. B cells isolated from peripheral blood of 21 pSS patients and 18 healthy controls were stimulated with TLR-7 and -9 ligands for 24 h before being analysed for the expression of certain surface markers and intracellular cytokine levels by flow cytometry. Secreted cytokines were measured by a multiplex cytokine assay. Patients with pSS had more naïve and less preswitched memory B cells compared to controls in unstimulated as well as via TLR-7 stimulated cells. Unstimulated and via TLR-7 stimulated B cells from pSS patients also had fewer IL-10(+) preswitched memory B cells. Moreover, TLR-7 and -9 stimulated B cells of pSS patients secreted increased amounts of several cytokines. B cells of pSS patients show a different responsiveness upon stimulation of TLR-7 and -9 compared to controls.
© 2015 The Foundation for the Scandinavian Journal of Immunology.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26332048     DOI: 10.1111/sji.12368

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  19 in total

Review 1.  Taking the STING out of TLR-driven autoimmune diseases: good, bad, or indifferent?

Authors:  Sudesh Pawaria; Shruti Sharma; Rebecca Baum; Kerstin Nündel; Patricia Busto; Ellen M Gravallese; Katherine A Fitzgerald; Ann Marshak-Rothstein
Journal:  J Leukoc Biol       Date:  2016-08-16       Impact factor: 4.962

Review 2.  Innate immunity in Sjögren's syndrome.

Authors:  Jeremy Kiripolsky; Liam G McCabe; Jill M Kramer
Journal:  Clin Immunol       Date:  2017-04-08       Impact factor: 3.969

3. 

Authors:  渊 任; 戈丹 崔; 永翔 高
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2021-12-25

Review 4.  Research progress on inflammatory mechanism of primary Sjögren syndrome.

Authors:  Yuan Ren; Gedan Cui; Yongxiang Gao
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2021-12-25

5.  TLR2 signals via NF-κB to drive IL-15 production in salivary gland epithelial cells derived from patients with primary Sjögren's syndrome.

Authors:  Margherita Sisto; Loredana Lorusso; Sabrina Lisi
Journal:  Clin Exp Med       Date:  2016-06-03       Impact factor: 3.984

6.  TLR7 Signaling Drives the Development of Sjögren's Syndrome.

Authors:  Yawen Wang; Annie Roussel-Queval; Lionel Chasson; Noël Hanna Kazazian; Laetitia Marcadet; Andrianos Nezos; Michael H Sieweke; Clio Mavragani; Lena Alexopoulou
Journal:  Front Immunol       Date:  2021-05-24       Impact factor: 7.561

7.  Analysis of Clinical Characteristics of Immune-Related Dry Eye.

Authors:  Hua Wang; Ping-Bao Wang; Ting Chen; Jing Zou; Ya-Jia Li; Xu-Fang Ran; Qiang-Xiang Li
Journal:  J Ophthalmol       Date:  2017-05-30       Impact factor: 1.909

Review 8.  Toll-like receptors in the pathogenesis of autoimmune diseases: recent and emerging translational developments.

Authors:  Laura Duffy; Steven C O'Reilly
Journal:  Immunotargets Ther       Date:  2016-08-22

Review 9.  Modulation of Apoptosis by Cytotoxic Mediators and Cell-Survival Molecules in Sjögren's Syndrome.

Authors:  Hideki Nakamura; Yoshiro Horai; Toshimasa Shimizu; Atsushi Kawakami
Journal:  Int J Mol Sci       Date:  2018-08-11       Impact factor: 5.923

Review 10.  Recent clinical trends in Toll-like receptor targeting therapeutics.

Authors:  Muhammad Ayaz Anwar; Masaud Shah; Jason Kim; Sangdun Choi
Journal:  Med Res Rev       Date:  2018-11-18       Impact factor: 12.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.